Phosphorus prodrugs of pyrazolo-substituted pyrimidine sgc stimulators
US-2024360164-A1 · Oct 31, 2024 · US
US11541088B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11541088-B2 |
| Application number | US-201917058861-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 23, 2019 |
| Priority date | May 25, 2018 |
| Publication date | Jan 3, 2023 |
| Grant date | Jan 3, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for treating a sleep disorder according to an embodiment of the present disclosure includes administering a composition comprising an extract of Hibiscus syriacus as an effective ingredient to a subject in need thereof. Because the Hibiscus syriacus extract of the present invention has an effect of improving sleep time deteriorated by stress, and an effect of reducing the content of corticosterone, which increases due to stress, and increasing the content of serotonin in blood. In addition, the composition has an effect of enhancing in a significant sense the expression of GABAR A α1 in cerebral cortex, which decreases due to stress, in a group administered with Hibiscus syriacus extract. As such, the composition comprising Hibiscus syriacus extract as an effective ingredient as an effective ingredient can be advantageously used as a functional health food composition or a pharmaceutical composition for preventing, ameliorating or treating sleeping disorders.
Opening claim text (preview).
What is claimed is: 1. A method for treating insomnia, the method comprising: administering a composition comprising an extract of Hibiscus syriacus flower as an effective ingredient to a subject in need thereof, wherein the extract of Hibiscus syriacus flower is an extract extracted with an ethanol solution; the insomnia is caused by an increased wake and a reduced REM (Rapid eye movement) sleep and NonREM (Non-Rapid eye movement) sleep during sleeping; and the extract of Hibiscus syriacus flower reduces wake and increases REM (Rapid eye movement) sleep and NonREM (Non-Rapid eye movement) sleep during sleeping to improve sleep quality. 2. The method of claim 1 , wherein the composition is in a formulation selected from the group consisting of a powder, a granule, a pill, a tablet, a capsule, a candy, a syrup, and a drink. 3. The method of claim 1 , wherein the composition is included in a health food. 4. The method of claim 1 , wherein the composition is a pharmaceutical composition. 5. The method of claim 4 , wherein the pharmaceutical composition further comprises at least one of a pharmaceutically acceptable carrier, a pharmaceutically acceptable vehicle, or a diluent.
Hypnotics; Sedatives · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
using mixed solvents, e.g. 70% EtOH · CPC title
having an effect on the health of the nervous system or on mental function · CPC title
Plant extracts, their artificial duplicates or their derivatives · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.